Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 최한곤 | - |
dc.date.accessioned | 2019-12-05T00:26:12Z | - |
dc.date.available | 2019-12-05T00:26:12Z | - |
dc.date.issued | 2019-10 | - |
dc.identifier.citation | NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, v. 21, Article no. 102042 | en_US |
dc.identifier.issn | 1549-9634 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S1549963419301261 | - |
dc.identifier.uri | https://repository.hanyang.ac.kr/handle/20.500.11754/117389 | - |
dc.description.abstract | Targeted, biocompatible, and synergistic “all in one” systems should be designed to combat the heterogeneity of cancer. In this study, we constructed a dual function nanosystem, copper sulfide nanoplatform loaded with the chemotherapeutic drug docetaxel wrapped by a conjugated polymer-peptide for targeted chemo-phototherapy. The nanoconstruct has been successfully designed with a size of 186.1 ± 5.2 nm, a polydispersity index of 0.18 ± 0.01, and zeta potential of −16.4 ± 0.1 mV. The enhanced uptake and near-infrared-responsive behavior of the nanosystem resulted in efficient drug release, photothermal ablation, effective cytotoxic activity, and potentiated reactive oxygen species generation. The induction of apoptotic markers, enhanced accumulation in the tumor site, and maximum tumor growth inhibition were seen during in vivo studies compared to non-targeted nanoformulations and free drug. Cumulatively, our results indicate that, with low systemic toxicity and better biocompatibility, this nanoconstruct could provide a promising strategy for treating prostate cancer. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | ELSEVIER SCIENCE BV | en_US |
dc.subject | Copper sulfide | en_US |
dc.subject | Nanoconstruct | en_US |
dc.subject | Docetaxel | en_US |
dc.subject | Lanreotide | en_US |
dc.subject | Somatostatin receptors | en_US |
dc.title | Multifaceted NIR-responsive polymer-peptide-enveloped drug-loaded copper sulfide nanoplatform for chemo-phototherapy against highly tumorigenic prostate cancer | en_US |
dc.type | Article | en_US |
dc.relation.volume | 21 | - |
dc.identifier.doi | 10.1016/j.nano.2019.102042 | - |
dc.relation.page | 102042-102052 | - |
dc.relation.journal | NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE | - |
dc.contributor.googleauthor | Poudel, Kishwor | - |
dc.contributor.googleauthor | Thapa, Raj Kumar | - |
dc.contributor.googleauthor | Gautam, Milan | - |
dc.contributor.googleauthor | Ou, Wenquan | - |
dc.contributor.googleauthor | Soe, Zar Chi | - |
dc.contributor.googleauthor | Gupta, Biki | - |
dc.contributor.googleauthor | Ruttala, Hima Bindu | - |
dc.contributor.googleauthor | Thuy, Hanh Nguyen | - |
dc.contributor.googleauthor | Dai, Phung Cao | - |
dc.contributor.googleauthor | Jeong, Jee-Heon | - |
dc.contributor.googleauthor | Ku, Sae Kwang | - |
dc.contributor.googleauthor | Choi, Han-Gon | - |
dc.contributor.googleauthor | Yong, Chul Soon | - |
dc.contributor.googleauthor | Kim, Jong Oh | - |
dc.relation.code | 2019042567 | - |
dc.sector.campus | E | - |
dc.sector.daehak | COLLEGE OF PHARMACY[E] | - |
dc.sector.department | DEPARTMENT OF PHARMACY | - |
dc.identifier.pid | hangon | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.